MANGALAMPharmaceuticals
Mangalam Drugs and Organics Ltd — PE Ratio & Valuation Analysis
₹27.15
-4.91%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E46.7x100.0% below avg
✅
100.0% Discount to Industry
MANGALAM P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹4.25 | ₹28 | 6.5x |
| 2023 | ₹0.80 | ₹98 | 122.7x |
| 2022 | ₹12.42 | ₹137 | 11x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Mangalam Drugs and Organics Ltd Valuation
Mangalam Drugs and Organics Ltd (MANGALAM) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, MANGALAM has traded at an average PE of 46.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
4.71%
Dividend Yield
0.00%
More on Mangalam Drugs and Organics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.